(2R,3S)-Azelaprag
(2R,3S)-N-(4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-4H-1,2,4-triazol-3-yl)-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide is an Apelin receptor agonist with an EC50 for Apelin receptors of 0.012 µM.(2R,3S)-N-(4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-4H-1,2,4-triazol-3-yl)-3-(5- methylpyrimidin-2-yl)butane-2-sulfonamide is used in the treatment of heart failure, atherosclerosis, obesity, diabetes mellitus, amyotrophic lateral sclerosis, coronary artery disease, hypertension, stroke and myocardial infarction.
| Catalog Number | T14390L |
| Research Area | GPCR/G Protein |
| Molecular Formula | C25H29N7O4S |
| CAS# | 2049979-31-7 |
| Purity | 98.69% |
| SMILES | N(S([C@@H]([C@@H](C)C=1N=CC(C)=CN1)C)(=O)=O)C=2N(C(=NN2)C=3C=C(C)C=NC3)C4=C(OC)C=CC=C4OC |
| Size | 5 mg |
| Supplier Page | https://www.targetmol.com/compound/(2R,3S)-Azelaprag |
| Additional Information | https://www.targetmol.com/datasheet/T14390L |
